US · USD
TGTX
TG Therapeutics Inc
- Day's range
- $51.34 – $54.11
- Day's volume
- $125.4M
- 52-week range
- $26.94 – $59.06
Follow TGTX in the Fuolio
See how TGTX weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountTGTX in numbers
- Market cap
- $8B
- P/E
- 18.09
- P/B
- 13.22
- Dividend yield (12m)
- 0.00%
- Net debt/EBITDA
- 1.42
TGTX trades at 18.09 times its earnings of the last 12 months.
TGTX price history
TGTX risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +56.92% | +307.42% | +243.36% |
| Volatility (annualized) | 49.29% | 53.41% | 79.80% |
| Largest drawdown | -11.52% | -35.55% | -77.63% |
| Positive months | 7/12 | 20/36 | 30/60 |
How much did investing in TGTX return?
$1,000.00 invested on 11/01/2021 would be worth $3,433.55 today.
- Value today in TGTX
- $3,433.55
- Return over the period
- +243.36%
- Return per year
- +28.44%
- In the S&P 500
- $1,712.05
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
TGTX fundamentals
Valuation
- P/E18.09
- P/B13.22
- EV/EBITDA59.96
- EV/EBIT60.02
- EV/Revenue10.23
- P/EBIT58.60
- P/S9.99
- P/OCF446.89
- P/FCF459.52
- Earnings yield1.67%
- PEG ratio—
- Earnings per share$2.88
- Book value per share$3.95
Debt
- Net debt$193.1M
- Net debt/EBITDA1.42
- Net debt/Equity0.32
- Debt/Equity1.23
- Current ratio4.27
- Quick ratio3.72
- Cash ratio2.06
Efficiency
- Gross margin82.37%
- EBITDA margin17.07%
- Operating margin17.05%
- Net margin55.22%
- Asset turnover0.49
Profitability
- ROE73.09%
- ROA26.93%
- ROIC17.10%
- Payout0.00%
Growth
- Revenue CAGR (5 years)219.17%
- Earnings CAGR (5 years)—
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
What is TGTX's fair price?
Two classic value formulas, with today's numbers. The current price is $52.19.
- Graham's fair price
- $16.00
- 69.34% below the price
√(22.50 × $2.88 × $3.95)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- —
- Does not apply to TGTX: it paid no distributions in the last five years.
Décio Bazin only bought stocks yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years over 6%.
Graham ignores growth and debt; Bazin assumes past distributions repeat. They are references to compare, not a buy recommendation.
TGTX's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | 10.64 | 202.04 | 207.68 | -8.73 | -7.80 | — | — | — |
| P/B | 7.35 | 21.26 | 16.43 | 29.55 | 11.44 | 14.08 | — | — |
| EV/EBITDA | 39.42 | 110.99 | 120.90 | — | — | — | — | — |
| Earnings per share | $2.80 | $0.15 | $0.08 | -$1.35 | -$2.44 | — | — | — |
| Book value per share | $4.06 | $1.42 | $1.04 | $0.40 | $1.66 | $3.69 | — | — |
| ROE | 69.01% | 10.52% | 7.91% | -338.47% | -146.78% | — | — | — |
| ROIC | 16.41% | 24.59% | 46.43% | — | — | — | — | — |
| Gross margin | 83.66% | 88.30% | 93.95% | 90.48% | 88.19% | — | — | — |
| EBITDA margin | 20.02% | 12.76% | 8.92% | -7,828.11% | -5,150.07% | — | — | — |
| Net margin | 72.56% | 7.11% | 5.44% | -7,120.29% | -5,204.07% | — | — | — |
| Net debt/EBITDA | 0.84 | -1.59 | -5.63 | — | — | — | — | — |
TGTX's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $616.3M | $329M | $233.7M | $2.8M | $6.7M | $152K |
| Cost of revenue | -$100.7M | -$38.5M | -$14.1M | -$265K | -$790K | — |
| Gross profit | $515.6M | $290.5M | $219.5M | $2.5M | $5.9M | — |
| EBITDA | $123.4M | $42M | $20.8M | -$218M | -$344.5M | — |
| EBIT | $123.3M | $41.9M | $20.6M | -$218.3M | -$344.8M | -$273.6M |
| Financial result | -$15.9M | -$16.3M | -$7.6M | -$5.5M | -$3.3M | -$5.8M |
| Income before tax | $107.4M | $25.6M | $13.1M | -$223.8M | -$348.1M | -$279.4K |
| Income tax | $339.8M | -$2.2M | -$390K | -$0 | -$0 | -$0 |
| Net income | $447.2M | $23.4M | $12.7M | -$198.3M | -$348.1M | — |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does TGTX pay dividends?
TGTX has no distributions on record.
About Tg Therapeutics
- Sector
- Manufacturing
Questions about TGTX
How much is TGTX today?
TGTX is at $52.19 (-3.19% on the day), last traded on 10/06/2026.
What are the P/E and P/B of TGTX?
TGTX trades at a P/E of 18.09 and a P/B of 13.22.
How much did TGTX return in 12 months?
TGTX returned 56.92% in 12 months, with annualized volatility of 49.29% and a largest drawdown of -11.52%.